News and Events

David Gilman Joins ClearView’s Leadership

ClearView is excited to welcome our new Partner, David Gilman. David has spent the past 25 years working to assist clients’ life science innovation strategies. David’s work has included a range of portfolio, drug development, investment, transactional and partnering strategies. While the therapeutic span of David’s work has crossed a broad swath of medicine, particular […]

News and Events

Kim Goh Joins the Leadership Team

ClearView is excited to announce that Kim Goh joins the firm’s leadership as a Principal. She has spent the majority of her career specifically focused on growth strategy in the life sciences industry. Kim has extensive experience leading strategic engagements across the life sciences industry. In that context, she has helped pharma and biotech companies […]

News and Events

Mike Roy joins ClearView as Head of Analytics

ClearView is excited to announce that Mike Roy is joining the firm as the Head of Analytics. He joins us from C1 Consulting/Charles River Associates where he led the advanced analytics group. Mike has spent seven years applying advanced analytics to new and old challenges facing commercial strategy teams within the life sciences industry, as […]

News and Events

Ryan Tubman joins ClearView as Principal

ClearView is excited to announce that Ryan Tubman is joining the firm as a Principal. He joins us from Charles River Associates and brings over 10 years of experience in consulting and healthcare. Ryan focuses on leveraging analytics and customer insights to develop evidence-based strategies for pharmaceutical and biotech organizations. His work spans early pipeline […]

News and Events

Ketan Kapadia joins ClearView as Managing Director

ClearView is excited to announce that Ketan Kapadia is joining the firm as Managing Director. Ketan draws on over twenty years of experience in the global life sciences industry to help leaders shape and implement their growth agenda. is work spans emerging and established biotechs / biopharmas, health technology entrants and investor communities.  Ketan has […]

News and Events